Shares of BioAge Labs, Inc. (BIOA) are up by 7.25% at $4.43 following the announcement of a multi-year research collaboration with Novartis (NVS) to discover novel targets for therapies that address age-related diseases and conditions.
Under the agreement, BioAge will receive up to $20 million in upfront payments and research funding, plus up to $530 million in potential future research, development, and commercial milestones.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.